ライフサイエンスコーパス: urogenital

1 (pelvic organ prolapse, colorectal-anal, and urogenital).

2 collections, gastrointestinal, vascular, and urogenital.

3 syphilis, 7.8% (n = 18/230); gonorrhea, 5.0% urogenital (10/201), 11.1% rectal (18/162), and 7.5% oro

4 7.5% oropharyngeal (15/201); chlamydia, 5.0% urogenital (10/201), 11.7% rectal (19/162), and 1.5% oro

5 276 had CT detected (217 urogenital, 249 rectum, 63 pharynx).There was no differe

6 4 females, 509 MSM), 116 had NG detected (75 urogenital, 83 rectum, 72 pharynx).

7 Nine patients (32%) had an underlying urogenital abnormality.

8 less likely to be consistently screened for urogenital (adjusted prevalence ratio [aPR], 0.86; 95% c

9 ing presumption that anatomic differences in urogenital anatomy confer protection from UTI in males;

10 al structures of the body plan including the urogenital and anorectal complex, and the perineum regio

11 Rare sporadic cases of meningococcal urogenital and anorectal infections, including urethriti

12 y vertebrate group to divide the cloaca into urogenital and anorectal portions, exhibit complex muscl

13 The urogenital and anorectal sinuses develop from the embryo

14 grow in anaerobic environments, such as the urogenital and anorectal tracts.

15 hypoplastic perineum tissue between external urogenital and anorectal tracts; hypospadias - ectopic v

16 nd future antimicrobials in the treatment of urogenital and extragenital gonorrhoea, are essential to

17 Sd animals exhibit aberrant axial skeleton, urogenital and gastrointestinal development similar to h

18 ic exchange has manifested itself in ocular, urogenital and LGV C. trachomatis strains, including the

19 thrive, ocular abnormalities, and defects in urogenital and limb morphogenesis.

20 element, ECR1, which is active in developing urogenital and other tissues; we propose that disruption

21 for the study of human Chlamydia trachomatis urogenital and respiratory tract infections.

22 Oropharyngeal, urogenital, and gastrointestinal tissues along with bloo

23 ow birth weight are strong predictors of the urogenital anomalies cryptorchidism (undescended testis)

24 line brain malformations were found in five, urogenital anomalies in nine, and a combination of both

25 tors cause both fetal growth restriction and urogenital anomalies was supported by comparison of urog

26 e co-twin was associated with higher risk of urogenital anomalies, suggesting an effect of relative f

27 The etiologies of the male urogenital anomalies--cryptorchidism and hypospadias--ar

28 etal growth restriction as a risk factor for urogenital anomalies.

29 tly of birth weight were not associated with urogenital anomalies.

30 ner-Wunderlich syndrome is a rare congenital urogenital anomaly characterised by uterus didelphys wit

31 tal anomalies was supported by comparison of urogenital anomaly risks in singletons and twins and by

32 udy, we find that, when mice investigate the urogenital areas of a conspecific animal, the urinary ph

33 ibitors (AI) are associated with significant urogenital atrophy, affecting quality of life and drug c

34 Chlamydia muridarum, a murine model of human urogenital C. trachomatis, with severely attenuated dise

35 pared with azithromycin for the treatment of urogenital chlamydia and about 7% increased efficacy for

36 omycin with doxycycline for the treatment of urogenital chlamydia infection among adolescents in yout

37 on receiving directly observed treatment for urogenital chlamydia infection, the efficacy of azithrom

38 ne twice daily (7 days) for the treatment of urogenital chlamydia infection.

39 fficacy of azithromycin for the treatment of urogenital chlamydia infection.

40 Urogenital Chlamydia serovars replicating in reproductiv

41 Rapid point of care test for detecting urogenital Chlamydia trachomatis infection in nonpregnan

42 Urogenital Chlamydia trachomatis infection remains preva

43 noninferior to Vibramycin for uncomplicated urogenital chlamydia treatment, better tolerated, and de

44 ly for 7 days for treatment of uncomplicated urogenital chlamydia.

45 nd nonpregnant women aged 19-45 years with a urogenital chlamydial diagnosis or a sexual partner with

46 capsule biosynthetic genes, indicating that urogenital colonization and urethritis caused by N. meni

47 i previously suggested to be associated with urogenital colonization.

48 2%), vascular complications in 5 (3.5%), and urogenital complications in 6 (4.1%).

49 isorder was diagnosed varied from 0.6% for a urogenital condition among persons with a developmental

50 he highest was 3.62 for eating disorders and urogenital conditions (95% CI, 3.11 to 4.22).

51 HIV positive patients (33.8) had higher urogenital Cq values than HIV negative patients (32.6) (

52 2) and women (30.7) aged <25 years had lower urogenital Cq values than men (32.8) and women (31.9) ag

53 017-2018, we enrolled women at high risk for urogenital CT into an 8-week prospective study.

54 pharyngeal GC, 10.2% for rectal GC, 8.4% for urogenital CT, 2.9% for pharyngeal CT, and 14.1% for rec

55 haryngeal GC, 50.4% for rectal GC, 81.4% for urogenital CT, 31.7% for pharyngeal CT, and 45.9% for re

56 we noted that the individual with a complex urogenital defect also harbored a heterozygous NPHP1 del

57 hat remained differentially methylated after urogenital development and used the most relevant tissue

58 in the epigenetic control of germ-cell fate, urogenital development, and gamete functions.

59 ular requirements for Dlg1 expression during urogenital development, we used a floxed Dlg1 allele and

60 immediately downstream of Wt1 during murine urogenital development.

61 able genetic reagents for in vivo studies of urogenital development.

62 rom the same primordium present during early urogenital development.

63 critical periods for forebrain division and urogenital development.

64 ther evaluated for their roles in regulating urogenital development.

65 e an important tool for researchers studying urogenital development/malformation in mouse models and

66 ulted in distinct phenotypes, with heart and urogenital developmental defects in Osr1(-/-) mice and w

67 ium has been associated with male and female urogenital disease syndromes, including urethritis, cerv

68 ns by which vaginal microbiomes help prevent urogenital diseases in women and maintain health are poo

69 ell and the causative agent of a spectrum of urogenital diseases.

70 es (uEVs) provide bio-markers for kidney and urogenital diseases.

71 mixed incontinence symptoms measured by the Urogenital Distress Inventory (UDI) long form; range, 0

72 apy yielded better outcomes over time on the Urogenital Distress Inventory and the Overactive Bladder

73 , defined as a reduction in the score on the Urogenital Distress Inventory of 70% or more and a respo

74 re, manifested as orthostatic hypotension or urogenital dysfunction, with combinations of parkinsonis

75 particularly to the presence of an essential urogenital enhancer located near the translocation break

76 Tbx18, identify a novel and likely essential urogenital enhancer, and introduce a new tool for dissec

77 tudies have shown that the hematopoietic and urogenital enhancers are located hundreds of kbp 5' and

78 ene as well as the distant hematopoietic and urogenital enhancers into a single, contiguous piece of

79 s in the United States may have adapted to a urogenital environment by loss of capsule and gene conve

80 aining biallelic inactivation of Pten in the urogenital epithelia.

81 twitching motility, and attachment to human urogenital epithelial cells were not restored by express

82 specifically inactivate Rb and/or p53 in the urogenital epithelium and the intestine.

83 men at both visual inspection and palpation; urogenital examination revealed a small left-sided palpa

84 Urogenital function remained stable at 12 months accordi

85 on pelvic autonomic nerves and postoperative urogenital function remains controversial.

86 revealed protective effects on postoperative urogenital function, and could be a better choice for ma

87 Of 21 994 MSM, 83.9% were tested for urogenital GC, 65.9% for pharyngeal GC, 50.4% for rectal

88 Of MSM tested, 11.1% tested positive for urogenital GC, 7.9% for pharyngeal GC, 10.2% for rectal

89 who have sex with men (MSM) be screened for urogenital GC/CT, rectal GC/CT, and pharyngeal GC.

90 he evaluation process for antimicrobials for urogenital gonorrhea treatment and encourages the consid

91 ged 15-60 years diagnosed with uncomplicated urogenital gonorrhea were randomly assigned to either ge

92 ntimicrobials for treatment of patients with urogenital gonorrhea.

93 mycin were highly effective for treatment of urogenital gonorrhea.

94 y, antibodies from women with C. trachomatis urogenital infection preferentially recognized proteins

95 emotherapy, control of Chlamydia trachomatis urogenital infection will likely require a vaccine.

96 Urogenital infection with Chlamydia trachomatis in some

97 primary outcome was microbiological cure of urogenital infections (negative follow-up culture) at 10

98 nt human pathogen responsible for a range of urogenital infections and pathologies.

99 Sexually transmitted and urogenital infections are typically managed by WHO-recom

100 Point-of-care testing for urogenital infections might improve case-finding and inf

101 h low prevalence of sexually transmitted and urogenital infections, are warranted.

102 ae, CT795, elicit strong immune responses in urogenital infections, but their role in trachomatous di

103 ith men, and is increasingly associated with urogenital infections.

104 ncrease LDL cholesterol and the incidence of urogenital infections.

105 ents with pneumococcal pneumonia and E. coli urogenital infections.

106 respiratory infection and those with E. coli urogenital infections.

107 ortal fibrosis with portal hypertension, and urogenital inflammation and scarring.

108 We report that a common urogenital inhabitant and opportunistic pathogen, group

109 e mice intravaginally with a human serovar D urogenital isolate that had undergone multiple in vitro

110 ched into clades that were separate from the urogenital isolates.

111 tal complications is enhanced after ART, and urogenital malformations can be present in boys, even in

112 gin of upper vagina fails to explain complex urogenital malformations like OHVIRA syndrome; the Acien

113 ttenuated for Tak1 were engrafted with fetal urogenital mesenchyme, the histopathology of the grafts

114 were tested by serial recombination with rat urogenital mesenchyme.

115 1 gram of azithromycin for the treatment of urogenital MG has decreased to approach 60%.

116 participants aged >/=12 years diagnosed with urogenital MG, and had microbial cure measured within 12

117 he zebrafish may offer insights into midline urogenital migration anomalies in humans.

118 malian embryo, DLGH1 is essential for normal urogenital morphogenesis and the development of skeletal

119 ally transmitted pathogens that colonize the urogenital mucosa.

120 presence of polyamines in fluids that bathe urogenital mucosal surfaces could alter the susceptibili

121 restricted pathogen that primarily colonizes urogenital mucosal surfaces.

122 y STI (OR, 2.0; 95% CI, 1.9-2.1), concurrent urogenital N. gonorrhoeae (OR, 2.4; 95% CI, 2.1-2.7), an

123 for any STI (OR2.0,95%CI1.9-2.1), concurrent urogenital N.gonorrhoeae (OR2.4,95%CI2.1-2.7), and concu

124 s: syphilis: 7.8%(n=18/230); gonorrhea: 5.0% urogenital(n=10/201), 11.1% rectal(n=18/162), and 7.5% o

125 .5% oropharyngeal(n=15/201); chlamydia: 5.0% urogenital(n=10/201), 11.7% rectal(n=19/162) and 1.5% or

126 ); 13.1% infected females and 71.8% MSM were urogenital negative.

127 x); 9.4% infected females and 67.3% MSM were urogenital negative.

128 Future urogenital Nm infection studies should focus on pathogen

129 intracranial hemorrhage or gastrointestinal, urogenital, or other bleeding.

130 ular biology and pathogenesis of this unique urogenital organism.

131 to their embryologic relationship with other urogenital organs, congenital anomalies of seminal vesic

132 icrobial peptides (AMPs) is a key feature of urogenital pathogenesis of the closely related species,

133 onstrated as an important chromosome-encoded urogenital pathogenicity factor of C. muridarum and the

134 to determine its individual contribution to urogenital pathogenicity.

135 atobium is a parasitic helminth which causes urogenital pathology.

136 h hematopoietic progenitor cell function and urogenital patterning.

137 If urogenital, plus rectal and pharyngeal, samples are anal

138 ncreased risk for retrograde ejaculation and urogenital problems.

139 fidence interval [CI], 1.6-37), history of a urogenital procedure (OR, 5.4; 95% CI, 2-14.7), and pres

140 The European Society of Urogenital Radiology (ESUR) updated its guidelines for p

141 lants, limiting their application in complex urogenital reconstruction.

142 and 69.3%(n=201) were screened for syphilis, urogenital, rectal, and oropharyngeal gonorrhea/chlamydi

143 and 69.3% (201) were screened for syphilis, urogenital, rectal, and oropharyngeal gonorrhea/chlamydi

144 osit a cord of cells along the length of the urogenital ridge.

145 tive interactions and lateral input from the urogenital ridges are required to drive HSC development

146 The MDs of urogenital ridges from mutant female embryos showed less

147 nges in the elongating Mullerian duct in rat urogenital ridges in organ culture manipulated by microi

148 to one NAAT container would cost the same as urogenital samples alone.

149 Discarded urogenital samples from 7,593 women (18 to 89 years old)

150 Urogenital schistosomiasis (egg-positive and/or haematur

151 ccelerate discoveries in the pathogenesis of urogenital schistosomiasis (UGS): (1) comparative genomi

152 rcinogenesis and infertility associated with urogenital schistosomiasis and discuss the basic hormona

153 g is required for key pathogenic features of urogenital schistosomiasis and that particular aspects o

154 We modeled urogenital schistosomiasis by injecting the bladder wall

155 his outbreak, showing how easily and rapidly urogenital schistosomiasis can be introduced and spread

156 Chronic urogenital schistosomiasis can lead to squamous cell car

157 The impact of urogenital schistosomiasis during pregnancy on birth out

158 approach to investigate the epidemiology of urogenital schistosomiasis in Corsica, aiming to elucida

159 es, as appears to be the case with increased urogenital schistosomiasis in humans around Lake Malawi

160 Urogenital schistosomiasis is a major public health prob

161 Urogenital schistosomiasis is a neglected tropical disea

162 The bladder pathology of urogenital schistosomiasis is caused by immune responses

163 stosoma mansoni infections, the pathology of urogenital schistosomiasis is related mainly to the egg

164 he summer of 2013, an unexpected outbreak of urogenital schistosomiasis occurred in Corsica, with mor

165 dings point to potential mechanisms by which urogenital schistosomiasis promotes bladder carcinogenes

166 bundance, density, and prevalence) and human urogenital schistosomiasis reinfection (prevalence and i

167 e-scale, high-resolution estimation of human urogenital schistosomiasis risk to support targeting of

168 Urogenital schistosomiasis was not significantly associa

169 Risk factors for urogenital schistosomiasis were characterized among 4,43

170 ns, we combined the first tractable model of urogenital schistosomiasis with an established mouse mod

171 We combined a mouse model of urogenital schistosomiasis with macrophage-depleting lip

172 e blood fluke Schistosoma haematobium causes urogenital schistosomiasis, a neglected tropical disease

173 developing world, is the causative agent of urogenital schistosomiasis, and is associated with a hig

174 Urogenital schistosomiasis, caused by Schistosoma haemat

175 Urogenital schistosomiasis, caused by the parasitic trem

176 nvestigational diagnostic tests utilized for urogenital schistosomiasis, highlighting new insights an

177 Urogenital schistosomiasis, infection with Schistosoma h

178 in many helminth infections, but its role in urogenital schistosomiasis, infection with Schistosoma h

179 Urogenital schistosomiasis, Schistosoma haematobium worm

180 Despite the significant global impact of urogenital schistosomiasis, the mechanisms of bladder gr

181 eventing or treating the bladder sequelae of urogenital schistosomiasis.

182 dicating that macrophages prevent death from urogenital schistosomiasis.

183 ma haematobium worms, the etiologic agent of urogenital schistosomiasis.

184 Chlamydia trachomatis urogenital serovars replicate predominantly in genital t

185 ing natural infections Chlamydia trachomatis urogenital serovars replicate predominantly in the epith

186 syndrome (n = 12), Hinman syndrome (n = 6), urogenital sinus (n = 4), and other pathologies (n = 4)

187 The mammalian urogenital sinus (UGS) develops in a sex specific manner

188 conditionally delete or stabilize Ctnnb1 in urogenital sinus (UGS) epithelium from which the prostat

189 rostate development, epithelial cells in the urogenital sinus (UGS) express Sonic Hedgehog (Shh) and

190 velopment by regulating Ar expression in the urogenital sinus (UGS) from which the prostate derives.

191 ncomplete separation of the hindgut from the urogenital sinus (UGS), absence of the ventral mesenchym

192 e prostate gland develops from the embryonic urogenital sinus (UGS).

193 tic buds as they emerge from the fetal mouse urogenital sinus (UGS).

194 The mammalian prostate arises from the urogenital sinus and few factors have been identified to

195 promoter activates at embryonic day 11.5 in urogenital sinus epithelium, we generated a conditional

196 e found that DeltaNp63-positive cells of the urogenital sinus generated all epithelial lineages of th

197 hich may account for development of a single urogenital sinus in females exposed to excessive androge

198 assaged spheres were recombined with E17 rat urogenital sinus mesenchyme and grafted in vivo, they ge

199 prostate tissue when combined with embryonic urogenital sinus mesenchyme and grafted in vivo.

200 s in a coculture system: Compared with mouse urogenital sinus mesenchyme or normal prostate fibroblas

201 For in vivo study, PrSPCs mixed with rat urogenital sinus mesenchyme were grafted under the renal

202 a and also exert morphogenic effects via the urogenital sinus mesenchyme.

203 of prostate epithelial buds into surrounding urogenital sinus mesenchyme.

204 elongation of the Mullerian duct towards the urogenital sinus occurs in part by proliferation at the

205 with the secretory and basal cells being of urogenital sinus origin.

206 of which is thought to be assimilated by the urogenital sinus primordial mesenchyme in males during f

207 ina depends on sexual differentiation of the urogenital sinus ridge, an epithelial thickening that fo

208 ia, masculinization of the urethra, a single urogenital sinus, and clitoral hypertrophy or ambiguous

209 controversial: a stem cell hypothesis with a urogenital sinus-derived progeny of all prostatic epithe

210 tips are enlarged and fail to merge with the urogenital sinus.

211 s the cloaca into dorsal hindgut and ventral urogenital sinus.

212 ith the Wolffian duct as it elongates to the urogenital sinus.

213 276 had CT detected (217 urogenital site, 249 rectum, 63 pharynx); 13.1% infected

214 4 females, 509 MSM), 116 had NG detected (75 urogenital site, 83 rectum, 72 pharynx); 9.4% infected f

215 h higher in extragenital sources compared to urogenital sources.

216 the detection of Mycoplasma genitalium Seven urogenital specimen types (n = 11,556) obtained from 1,7

217 otic resistance phenotype were determined in urogenital specimens collected from female and male subj

218 the detection of M. genitalium, using 22,150 urogenital specimens from both symptomatic and asymptoma

219 ing was performed on C. trachomatis-positive urogenital specimens obtained from patients at enrollmen

220 Urogenital specimens were obtained from 13 patients who

221 ctive collection study using male and female urogenital specimens; supportive data from archived spec

222 polymorphic among C. trachomatis ocular and urogenital strains.

223 erplasia (56% vs 19%; P = .04), a history of urogenital surgery (63% vs 28%; P = .001), and presentat

224 male endocervical swabs and 84 male urine or urogenital swab specimens) were screened using the COBAS

225 women aged 18 years or older with or without urogenital symptoms at risk of acquiring sexually transm

226 Participants reporting urogenital symptoms had a significantly elevated risk of

227 ually asymptomatic, they may lead to various urogenital symptoms, including infertility.

228 considered in young persons presenting with urogenital symptoms.

229 erview that included questions about current urogenital symptoms.

230 perative to understanding these inflammatory urogenital syndromes, particularly in females, consideri

231 e, nerves/ganglia and epithelia of the lower urogenital system are also presented.

232 To date, there is no case of penile or urogenital system metastasis from CCA described in the l

233 confirmed Nrip1 expression in the developing urogenital system of the mouse.

234 for bacteria and harmful substances into the urogenital system, but not in further centrally located

235 Pax2 is essential for the development of the urogenital system, neural tube, otic vesicle, optic cup

236 ssential for development of the neural tube, urogenital system, optic vesicle, optic cup and optic tr

237 er DLG1 and CASK cooperate in the developing urogenital system, we generated mice deficient in both D

238 eloped an anatomical ontology for the murine urogenital system.

239 ional regulators in the developing mammalian urogenital system.

240 oinformaticians interested in the developing urogenital system.

241 h resides in the vasculature surrounding the urogenital system.

242 ains protein 2 (FHL2) is highly expressed in urogenital systems and has been implicated in Wnt/beta-c

243 ients presenting with extrapulmonary TB have urogenital TB (UG-TB), which can easily be overlooked ow

244 t combinations of anorectal, pharyngeal, and urogenital testing based on age, sex, and sexual activit

245 Urogenital testing misses extragenital Neisseria gonorrh

246 Chronically the effects of normal urogenital tissue exposure can lead to urinary frequency

247 and histological rejection classification of urogenital tissue transplants using a new rat heterotopi

248 e significance of the HDPs in protecting the urogenital tissues from infection.

249 Urinary stasis, surgical disruption of urogenital tissues, and a bacterial capsule characterist

250 Purpose To evaluate urogenital toxicity and oncologic outcome of MRI-transre

251 ized prostate cancer was associated with low urogenital toxicity and promising oncologic outcomes.

252 Primary end point was the urogenital toxicity profile of focal IRE by using partic

253 n 88.2% of the patients), lungs (26.4%), the urogenital tract (17.6%), and eyes (8.8%).

254 which is distinct from the lineages causing urogenital tract (UGT) and lymphogranuloma venerum disea

255 olecular anatomy of the developing mammalian urogenital tract (UGT).

256 eaplasma species commonly colonize the adult urogenital tract and are implicated in invasive diseases

257 of a decrease in average wet weights of the urogenital tract and prostate gland in 1 and 2 mg DATS-t

258 ection with Chlamydia muridarum in the mouse urogenital tract can induce both protective immunity and

259 ransmitted parasite that colonizes the human urogenital tract causing infections that range from asym

260 t, emphasising its etiology as a disorder of urogenital tract development.

261 te that binds to the epithelium of the human urogenital tract during infection.

262 So far, the urogenital tract has been considered to lack this cell t

263 of UTIs worldwide and can also colonize the urogenital tract in a phenomenon known as asymptomatic b

264 Trichomonas vaginalis is a parasite of the urogenital tract in men and women, with a worldwide pres

265 hich expression of these pumps in the female urogenital tract incurs a fitness cost for pathogenic Ne

266 leading cause of preventable blindness, and urogenital tract infection by Chlamydia causes sexually

267 Mycoplasma genitalium causes persistent urogenital tract infection in humans.

268 ways, was evaluated in a Chlamydia muridarum urogenital tract infection model.

269 yndrome is a very rare congenital anomaly of urogenital tract involving Mullerian ducts and mesonephr

270 upport of the first hypothesis, here we show urogenital tract isolates representing the most common P

271 Trichomonas vaginalis colonizes the urogenital tract of humans and causes trichomonosis, the

272 Mycoplasma penetrans is a urogenital tract pathogen implicated in the deterioratio

273 Malformation of the urogenital tract represents a considerable paediatric bu

274 endocrine, not epithelial, origin within the urogenital tract to give prostate cancer in the males an

275 phenotype, suppressing absolute and relative urogenital tract weights by 86% and 85%, respectively, a

276 ored the innate protective mechanisms of the urogenital tract with the aim of boosting such defences

277 extensively to cells of the digestive tract, urogenital tract, and kidneys.

278 During development of the urogenital tract, fibroblast growth factor 8 (Fgf8) is e

279 rvum, an opportunistic pathogen of the human urogenital tract, has been implicated in contributing to

280 , involved in the development of the kidney, urogenital tract, pancreas, liver, brain, and parathyroi

281 a survival or transmission advantage in the urogenital tract, perhaps via increased resistance to co

282 t pH values found in the body and the female urogenital tract, respectively.

283 hronically contaminate and infect the female urogenital tract, thereby potentially contributing to th

284 pulation rather than novel adaptation to the urogenital tract.

285 nizes the nasopharynx and rarely infects the urogenital tract.

286 ver enzymes, and congenital anomalies of the urogenital tract.

287 in the developing intermediate mesoderm and urogenital tract.

288 mitted, opportunistic pathogens of the human urogenital tract.

289 biology of chlamydial dissemination from the urogenital tract.

290 al surfaces of the gut, the airways, and the urogenital tract.

291 hat orchestrate embryonic development of the urogenital tract.

292 bacterial pathogen that infects the eyes and urogenital tract.

293 a, is capable of invading and colonizing the urogenital tract.

294 l resident of the human gastrointestinal and urogenital tracts and also a prevalent fungal pathogen.

295 of other proinflammatory cytokines in mouse urogenital tracts during the early stages of the infecti

296 lar courses of chlamydial infection in their urogenital tracts, suggesting that Chlamydia-activated c

297 ors of the respiratory, gastrointestinal and urogenital tracts.

298 ng the eyes, lungs, and gastrointestinal and urogenital tracts.

299 encoding human VAMP7 mimicked the defective urogenital traits observed in boys with masculinization

300 he newly recognized association of PVAN with urogenital tumors.